Correction to: Preclinical Identification of Sulfasalazine’s Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling (Biomedicines, (2022), 10, 2, (377), 10.3390/biomedicines10020377)

研究成果: 雜誌貢獻評論/辯論同行評審

摘要

In the original publication, there is a mistake in Figure 11B as published [1]. The images of the colony formation assay are misplaced. The corrected Figure 11 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
原文英語
文章編號547
期刊Biomedicines
13
發行號3
DOIs
出版狀態已發佈 - 3月 2025

ASJC Scopus subject areas

  • 醫藥(雜項)
  • 一般生物化學,遺傳學和分子生物學

指紋

深入研究「Correction to: Preclinical Identification of Sulfasalazine’s Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling (Biomedicines, (2022), 10, 2, (377), 10.3390/biomedicines10020377)」主題。共同形成了獨特的指紋。

引用此